Announcement on Abnormal Fluctuations in Stock Trading
Filed with SSE · · 3 pages · Chinese
Sinocelltech Group Limited on 6ix
Earlier from Sinocelltech
- Announcement on Equity Change of Shareholder with Over 5% Shares Reaching 1% Scale and Result of Shareholding Reduction
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval of Drug Clinical Trial for Holding Subsidiary's Product SCTB39G
- Announcement on Resolution of the 1st Extraordinary General Meeting in 2025
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval of Drug Clinical Trial for Holding Subsidiary's Product SCTB39-1
- Indicative Announcement on Changes in Shareholder's Equity
Later from Sinocelltech
- Announcement on Voluntary Disclosure of the Receipt of the Drug Clinical Trial Approval Notice for Product SCT640C by a Holding Subsidiary
- Announcement on Acceptance of Application for Issuance of A-shares to Specific Objects in 2025 by SSE
- 2025 Semi-annual Report
- Announcement on Attending Collective Performance Briefing for Innovative Drug Industry on Semi-annual SSE STAR Market 2025
- Indicative Announcement on Reply to Letter of Review and Inquiry on Application Documents for Shares Issuance to Specific Objects
Follow Sinocelltech into a list and get an email when it puts out news.
Follow Sinocelltech